APA Alıntı

Levallet, G., Dubois, F., Fouret, P., Antoine, M., Brosseau, S., Bergot, E., . . . Zalcman, G. (2016). MSH2/BRCA1 expression as a DNA-repair signature predicting survival in early–stage lung cancer patients from the IFCT-0002 Phase 3 Trial. Oncotarget.

Chicago Stili Alıntı

Levallet, Guénaëlle, et al. "MSH2/BRCA1 Expression As a DNA-repair Signature Predicting Survival in Early–stage Lung Cancer Patients From the IFCT-0002 Phase 3 Trial." Oncotarget 2016.

MLA Alıntı

Levallet, Guénaëlle, et al. "MSH2/BRCA1 Expression As a DNA-repair Signature Predicting Survival in Early–stage Lung Cancer Patients From the IFCT-0002 Phase 3 Trial." Oncotarget 2016.